{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T16:55:00Z","timestamp":1662051300721},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00063-018-0470-6","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T11:19:14Z","timestamp":1535455154000},"page":"664-671","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["10\u00a0Kernaussagen zum Embolic Stroke of Undetermined Source und kryptogenen Schlaganfall"],"prefix":"10.1007","volume":"113","author":[{"given":"P.","family":"B\u00f6ttger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lemm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"470_CR1","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","volume":"374","author":"JL Saver","year":"2016","unstructured":"Saver JL (2016) CLINICAL PRACTICE. Cryptogenic Stroke. N\u00a0Engl J Med 374:2065","journal-title":"N Engl J Med"},{"key":"470_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/01.STR.15.4.740","volume":"15","author":"SC Kunitz","year":"1984","unstructured":"Kunitz SC, Gross CR, Heyman A et\u00a0al (1984) The pilot Stroke Data Bank: definition, design, and data. Stroke 15:740","journal-title":"Stroke"},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/01.STR.19.5.547","volume":"19","author":"MA Foulkes","year":"1988","unstructured":"Foulkes MA, Wolf PA, Price TR et\u00a0al (1988) The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 19:547","journal-title":"Stroke"},{"key":"470_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ et\u00a0al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a\u00a0multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35","journal-title":"Stroke"},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ana.20617","volume":"58","author":"H Ay","year":"2005","unstructured":"Ay H, Furie KL, Singhal A et al (2005) An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 58:688","journal-title":"Ann Neurol"},{"key":"470_CR6","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1161\/STROKEAHA.107.490896","volume":"38","author":"H Ay","year":"2007","unstructured":"Ay H, Benner T, Arsava EM et\u00a0al (2007) A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 38:2979","journal-title":"Stroke"},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB et\u00a0al (2014) Embolic strokes of undetermined source: the case for a\u00a0new clinical construct. Lancet Neurol 13:429","journal-title":"Lancet Neurol"},{"key":"470_CR8","unstructured":"https:\/\/www.jnj.com\/media-center\/press-releases\/navigate-esus-study-stopped-early-due-to-comparable-efficacy-in-treatment-arms\n                    \n                  . Zugegriffen: 27.08.2018"},{"key":"470_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR et\u00a0al (2012) Subclinical atrial fibrillation and the risk of stroke. N\u00a0Engl J Med 366:120","journal-title":"N Engl J Med"},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","volume":"129","author":"M Brambatti","year":"2014","unstructured":"Brambatti M, Connolly SJ, Gold MR et\u00a0al (2014) Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 129:2094","journal-title":"Circulation"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1161\/STROKEAHA.114.006364","volume":"45","author":"H Kamel","year":"2014","unstructured":"Kamel H, Soliman EZ, Heckbert SR et al (2014) P\u2011wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke 45:2786","journal-title":"Stroke"},{"key":"470_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/STROKEAHA.109.577775","volume":"41","author":"A Harloff","year":"2010","unstructured":"Harloff A, Simon J, Brendecke S et\u00a0al (2010) Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke. Stroke 41:1145","journal-title":"Stroke"},{"key":"470_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.echo.2013.04.004","volume":"26","author":"MY Abushora","year":"2013","unstructured":"Abushora MY, Bhatia N, Alnabki Z et\u00a0al (2013) Intrapulmonary shunt is a\u00a0potentially unrecognized cause of ischemic stroke and transient ischemic attack. J\u00a0Am Soc Echocardiogr 26:683","journal-title":"J Am Soc Echocardiogr"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/heartjnl-2011-300470","volume":"97","author":"KT Ahn","year":"2011","unstructured":"Ahn KT, Choi JH, Park SW (2011) Pulmonary arteriovenous fistula in a\u00a0patient with cryptogenic stroke. Heart 97:2093","journal-title":"Heart"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1161\/STROKEAHA.107.496513","volume":"39","author":"M Mazighi","year":"2008","unstructured":"Mazighi M, Labreuche J, Gongora-Rivera F et al (2008) Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 39:1142","journal-title":"Stroke"},{"key":"470_CR16","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1161\/01.STR.30.12.2513","volume":"30","author":"GW Petty","year":"1999","unstructured":"Petty GW, Brown RD Jr, Whisnant JP et al (1999) Ischemic stroke subtypes: a\u00a0population-based study of incidence and risk factors. Stroke 30:2513","journal-title":"Stroke"},{"key":"470_CR17","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/hs1201.100209","volume":"32","author":"PL Kolominsky-Rabas","year":"2001","unstructured":"Kolominsky-Rabas PL, Weber M, Gefeller O et al (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a\u00a0population-based study. Stroke 32:2735","journal-title":"Stroke"},{"key":"470_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0002-9149(02)02496-7","volume":"90","author":"JR Kizer","year":"2002","unstructured":"Kizer JR, Silvestry FE, Kimmel SE et\u00a0al (2002) Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography. Am J Cardiol 90:395","journal-title":"Am J Cardiol"},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/hs0302.104543","volume":"33","author":"C Lamy","year":"2002","unstructured":"Lamy C, Giannesini C, Zuber M et al (2002) Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 33:706","journal-title":"Stroke"},{"key":"470_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.10644","volume":"54","author":"OY Bang","year":"2003","unstructured":"Bang OY, Lee PH, Joo SY et\u00a0al (2003) Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 54:227","journal-title":"Ann Neurol"},{"issue":"4","key":"470_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","volume":"48","author":"RG Hart","year":"2017","unstructured":"Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ (2017) Embolic stroke of undetermined source: a systematic review and clinical update. Stroke 48(4):867\u2013872","journal-title":"Stroke"},{"key":"470_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/STROKEAHA.114.007240","volume":"46","author":"G Ntaios","year":"2015","unstructured":"Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K et\u00a0al (2015) Embolic Strokes of Undetermined Source in the Athens Stroke Registry: a descriptive analysis. Stroke 46:176\u2013181","journal-title":"Stroke"},{"key":"470_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/01.SMJ.0000144612.87267.36","volume":"97","author":"AM Yahia","year":"2004","unstructured":"Yahia AM, Shaukat AB, Kirmani JF et\u00a0al (2004) Treatable potential cardiac sources of embolism in patients with cerebral ischemic events: a\u00a0selective transesophageal echocardiographic study. South Med\u00a0J 97:1055","journal-title":"South Med J"},{"key":"470_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000047772","volume":"13","author":"P Cerrato","year":"2002","unstructured":"Cerrato P, Imperiale D, Priano L et\u00a0al (2002) Transoesophageal echocardiography in patients without arterial and major cardiac sources of embolism: difference between stroke subtypes. Cerebrovasc Dis 13:174","journal-title":"Cerebrovasc Dis"},{"key":"470_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/ene.12673","volume":"22","author":"AC Fonseca","year":"2015","unstructured":"Fonseca AC, Ferro JM (2015) Cryptogenic stroke. Eur J Neurol 22:618","journal-title":"Eur J Neurol"},{"key":"470_CR26","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1161\/STROKEAHA.114.005539","volume":"45","author":"AL Liberman","year":"2014","unstructured":"Liberman AL, Daruwalla VJ, Collins JD et\u00a0al (2014) Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale. Stroke 45:2324","journal-title":"Stroke"},{"key":"470_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1161\/01.STR.0000106137.42649.AB","volume":"35","author":"SC Cramer","year":"2004","unstructured":"Cramer SC, Rordorf G, Maki JH et\u00a0al (2004) Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 35:46","journal-title":"Stroke"},{"key":"470_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N\u00a0Engl J Med 333:1581","journal-title":"N Engl J Med"},{"key":"470_CR29","doi-asserted-by":"publisher","first-page":"e601S","DOI":"10.1378\/chest.11-2302","volume":"141","author":"MG Lansberg","year":"2012","unstructured":"Lansberg MG, O\u2019Donnell MJ, Khatri P et al (2012) Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e601S","journal-title":"Chest"},{"key":"470_CR30","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR et\u00a0al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a\u00a0guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45:2160","journal-title":"Stroke"},{"key":"470_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000092331","volume":"22","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Prabhakaran S, Thompson JL et al (2006) Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis 22:4","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"470_CR32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N\u00a0Engl J Med 377(11):1022\u20131032","journal-title":"N Engl J Med"},{"issue":"11","key":"470_CR33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sj\u00f6strand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L (2017) Gore REDUCE clinical study investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N\u00a0Engl J Med 377(11):1033\u20131042","journal-title":"N Engl J Med"},{"key":"470_CR34","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.STR.31.5.1062","volume":"31","author":"GW Petty","year":"2000","unstructured":"Petty GW, Brown RD Jr, Whisnant JP et al (2000) Ischemic stroke subtypes: a\u00a0population-based study of functional outcome, survival, and recurrence. Stroke 31:1062","journal-title":"Stroke"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-018-0470-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-018-0470-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-018-0470-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T23:41:57Z","timestamp":1566949317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-018-0470-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1007\/s00063-018-0470-6","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"28 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0B\u00f6ttger und H.\u00a0Lemm geben an, dass kein Interessenkonflikt besteht. M.\u00a0Grond hat Reisekostenerstattungen sowie Honorare f\u00fcr die Teilnahme an klinischen Studien, die Mitarbeit in Advisory Boards und Vortr\u00e4ge von den Firmen Bayer Vital, Boehringer Ingelheim, Bristol-Myers-Sqibb, Daiichi-Sankyo, Medtronics und Pfizer erhalten. M.\u00a0Buerke hat Reisekostenerstattungen sowie Honorare f\u00fcr die Mitarbeit in Advisory Boards und f\u00fcr Vortr\u00e4ge von den Firmen Bayer Vital, Boehringer Ingelheim, Bristol-Myers-Sqibb, Daiichi-Sankyo und Pfizer erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}